Literature DB >> 1729105

The alternation between atrial flutter and atrial fibrillation.

P A Tunick1, L McElhinney, T Mitchell, I Kronzon.   

Abstract

Atrial fibrillation and atrial flutter share a common reentrant mechanism. However, the relationship between these arrhythmias has not been systemically studied to date. To evaluate the degree to which these arrhythmias may alternate, consecutive Holter monitor recordings which showed fibrillation or flutter in 96 patients were reviewed. One half of the patients were studied after open-heart surgery and the other half for varying indications. One quarter of the patients had atrial flutter in addition to fibrillation, and this alternation with flutter was significantly associated with the use of a type 1A antiarrhythmic drug (p = 0.007), but not with the use of digoxin or beta blockers (p = NS for both). Furthermore, this alternation with flutter was more common in the postoperative group (p = 0.01). A history of embolization was less common in patients who were in the postoperative group (p = 0.003) and patients who had flutter in addition to fibrillation (p = 0.05).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729105     DOI: 10.1378/chest.101.1.34

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Atrial Flutter, Typical and Atypical: A Review.

Authors:  Francisco G Cosío
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

2.  Early versus late atrial fibrillation after atrial flutter ablation.

Authors:  Emmanuel Loutrianakis; Tawfik Barakat; Brian Olshansky
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

3.  A re-analysis of our current understanding of isthmus-dependent atrial flutter: some gaps, some hypotheses.

Authors:  A Nabar
Journal:  Indian Pacing Electrophysiol J       Date:  2001-10-01

Review 4.  The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.

Authors:  O A Obel; A J Camm
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 3.923

Review 5.  Prevention of and medical therapy for atrial arrhythmias in heart failure.

Authors:  A U Khand; J G F Cleland; P C Deedwania
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.